BUMEX Drug Patent Profile

Name: BUMEX Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which patents cover Bumex, and when can generic versions of Bumex launch?

Bumex is a drug marketed by Validus Pharms and is included in two NDAs.

The generic ingredient in BUMEX is bumetanide. There is one drug master file entry for this compound. Forty suppliers are listed for this compound. Additional details are available on the bumetanide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Bumex

A generic version of BUMEX was approved as bumetanide by SAGENT on January 27^th, 1995.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for BUMEX?
What are the global sales for BUMEX?
What is Average Wholesale Price for BUMEX?

Summary for BUMEX

US Patents:	0
Applicants:	1
NDAs:	2
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	79
Patent Applications:	4,597
What excipients (inactive ingredients) are in BUMEX?	BUMEX excipients list
DailyMed Link:	BUMEX at DailyMed

Drug patent expirations by year for BUMEX

Pharmacology for BUMEX

Drug Class	Loop Diuretic
Physiological Effect	Increased Diuresis at Loop of Henle

US Patents and Regulatory Information for BUMEX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Validus Pharms	BUMEX	bumetanide	INJECTABLE;INJECTION	018226-001	Feb 28, 1983		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-003	Jun 14, 1985	AB	RX	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-002	Feb 28, 1983	AB	RX	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-001	Feb 28, 1983	AB	RX	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for BUMEX

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-002	Feb 28, 1983	⤷ Start Trial	⤷ Start Trial
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-003	Jun 14, 1985	⤷ Start Trial	⤷ Start Trial
Validus Pharms	BUMEX	bumetanide	INJECTABLE;INJECTION	018226-001	Feb 28, 1983	⤷ Start Trial	⤷ Start Trial
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-003	Jun 14, 1985	⤷ Start Trial	⤷ Start Trial
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-001	Feb 28, 1983	⤷ Start Trial	⤷ Start Trial
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-003	Jun 14, 1985	⤷ Start Trial	⤷ Start Trial
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-002	Feb 28, 1983	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for BUMEX

See the table below for patents covering BUMEX around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Austria	308069		⤷ Start Trial
Belgium	743744		⤷ Start Trial
Bulgaria	17812		⤷ Start Trial
Brazil	6915200		⤷ Start Trial
Switzerland	532559	Verfahren zur Herstellung von Sulfamylbenzoesäure-Derivaten und deren Verwendung	⤷ Start Trial
Cyprus	697	New sulphamyl-benzoic acid derivatives	⤷ Start Trial
Germany	1964503		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

AI Deep Research

Questions you can ask:

Summary for BUMEX

Pharmacology for BUMEX

Make Better Decisions: Try a trial or see plans & pricing